This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Stephen M. Hahn, M.D., Commissioner of Food and Drugs

Event Date: 09/21/2020
Location: Virtual
Subject: FDA Compounding Quality Center of Excellence Conference: Working Together for Patient Safety
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry, government, media and other registered guests

Event Date: 09/25/2020
Location: Virtual
Subject: Transdisciplinary Global Research in Rare Central Nervous System (CNS) Tumors: A Framework to Impact Outcomes Across CNS Disease
FDA Participant/Group: N/A
Non FDA Participant/Group: Academia, media, government and other registered guests

Official Name: Amy Abernethy, M.D., Ph.D, Principal Deputy Commissioner

Event Date: 09/21/2020
Location: Virtual
Subject: Health Level Seven (HL7) Annual Meeting: Fireside Chat
FDA Participant/Group: N/A
Non FDA Participant/Group: Academia, industry, and other stakeholders

Event Date: 09/22/2020
Location: Virtual
Subject: An International Framework for Real-World Evidence: Fireside Chat
FDA Participant/Group: N/A
Non FDA Participant/Group: Patients, academia, industry and other stakeholders

Event Date: 09/22/2020
Location: Virtual
Subject: DPharm: Disruptive Innovations US: Modernizing Clinical Trials Keynote: Q&A with FDA
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, academia, and other stakeholders

Event Date: 09/23/2020
Location: Virtual
Subject: Cigna Data Analytics Listening Session
FDA Participant/Group: LAURA ROE;
Non FDA Participant/Group: Saif Rathore (Cigna); Amar Bhat, Carla Rodriguez, Susan Winckler (Reagan-Udall Foundation); Brian Anderson (Mitre Corporation); Nirosha Mahendraratnam Lederer (Duke-Margolis Center for Health Policy);

Event Date: 09/24/2020
Location: Virtual
Subject: National Academies of Medicine Leadership Consortium Members Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: Academia, industry, and other stakeholders

Official Name: Anand Shah, M.D., Deputy Commissioner for Medical and Scientific Affairs

No Significant Event

Official Name: Anna Abram, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

Event Date: 09/21/2020
Location: Virtual
Subject: Food Safety Issues of Mutual Interest
FDA Participant/Group: CAITLIN BOON; LARRY MORRIS; NINA ZIMDAHL; JEFFREY FARRAR;
Non FDA Participant/Group: Barbara Glenn, Bob Ehart, Joe Reardon, Zach Gihorski (National Association of State Departments of Agriculture);

Event Date: 09/22/2020
Location: Virtual
Subject: Institute for Food Safety and Health Annual Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: Members from the food and beverage industry, academia, and government

Event Date: 09/22/2020
Location: Virtual
Subject: USDA Public Meeting on Salmonella
FDA Participant/Group: N/A
Non FDA Participant/Group: Members from the food and beverage industry, academia, and government

Event Date: 09/23/2020
Location: Virtual
Subject: Food Safety Culture
FDA Participant/Group: Several FDA leaders and staff
Non FDA Participant/Group: Several members from the Alliance to Stop Illness

Event Date: 09/24/2020
Location: Virtual
Subject: United Fresh Produce Association's Washington Conference
FDA Participant/Group: N/A
Non FDA Participant/Group: Several members from the produce and agricultural industry, academia, and government

Event Date: 09/25/2020
Location: Virtual
Subject: National Grocers Association Executive Conference
FDA Participant/Group: N/A
Non FDA Participant/Group: Several executives and members from the food retail and wholesale industry

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

No Significant Event

Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Heidi Rebello, Acting Associate Commissioner for External Affairs

No Significant Event

Official Name: RADM Denise Hinton, Chief Scientist

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Acting Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 09/21/2020
Location: Virtual
Subject: World Economic Forum: Enabling COVID-Era Cross-Border Travel Webinar: Opening Remarks
FDA Participant/Group: N/A
Non FDA Participant/Group: Representatives from government, business, international organizations and the public

Event Date: 09/21/2020
Location: Virtual
Subject: Massachusetts Institute of Technology: Integrated and Continuous Biologics Pharmaceutical Manufacturing Webinar: Opening Remarks
FDA Participant/Group: N/A
Non FDA Participant/Group: Representatives from the biologics pharmaceutical industry

Event Date: 09/23/2020
Location: Virtual
Subject: FasterCures: Data Collection for Cell and Gene Therapies
FDA Participant/Group: N/A
Non FDA Participant/Group: Members of FasterCures

Event Date: 09/24/2020
Location: Virtual
Subject: American Society of Gene & Cell Therapy Policy Summit: Streamlining Development by Leveraging Applications on File: Concepts in Development
FDA Participant/Group: N/A
Non FDA Participant/Group: Members of the American Society of Gene & Cell Therapy

Event Date: 09/24/2020
Location: Virtual
Subject: Silicon Valley Bank Leerink CybeRx Series: Vaccine Forum: Fireside Chat
FDA Participant/Group: N/A
Non FDA Participant/Group: Several representatives of industry

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

Event Date: 09/22/2020
Location: Virtual
Subject: National Evaluation System for Health Technology Forum; Real-World Evidence: Current Perspectives and Future Innovation
FDA Participant/Group: N/A
Non FDA Participant/Group: Kathleen Blake (American Medical Association); Diane Pickles (American Heart Association); Naomi Aronson (Blue Cross Blue Shield Association); Sandra Siami (Medical Device Innovation Consortium );

Event Date: 09/23/2020
Location: Virtual
Subject: University of Southern California Body Computing Conference: What Policy and Legislative Changes Are Needed to Continue to Digitally Transform Healthcare After COVID-19
FDA Participant/Group: N/A
Non FDA Participant/Group: SEN William Cassidy (R-LA);

Event Date: 09/23/2020
Location: Virtual
Subject: International Medical Device Regulators Forum Annual Conference
FDA Participant/Group: MELISSA TORRES;
Non FDA Participant/Group: Medical device regulators

Event Date: 09/25/2020
Location: Virutal
Subject: Medical Device Manufacturers Association Executive Forum: CDRH Update
FDA Participant/Group: N/A
Non FDA Participant/Group: Medical device manufacturers

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

No Significant Event

Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Stacy Cline Amin, Chief Counsel

No Significant Event